Key Takeaways Compounded versions of Ozempic and Zepbound are still readily availableFederal regulators had planned to clamp ...
April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs. Lilly is ...
The Food and Drug Administration announced that branded tirzepatide, the active ingredient in Eli Lilly's weight loss drug Zepbound, is no longer in short supply. That decision will largely prevent ...
Add Yahoo as a preferred source to see more of our stories on Google. April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results